Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Atkore International Group Q2 FY2026 Earnings Call - Data Center & Solar Momentum Offsets PVC Headwinds
Atkore delivered a sequential improvement in Q2 FY2026, with net sales rising to $731 million and adjusted EPS of $1.23. The company’s earnings were weighed down by a $136.5 million pre-tax charge to ...
- Net sales rose 5% year-over-year to $731 million, marking the first quarterly sales increase since Q4 FY2022, driven by a 5% jump in organic volume and a 1.5% increase in average selling prices.
- Adjusted EPS came in at $1.23, significantly lower than the $2.04 reported in the prior year, primarily due to a $136.5 million pre-tax charge to settle two classes in PVC pipe antitrust litigation.
- Management confirmed full-year guidance remains intact, projecting mid-single-digit organic volume growth, adjusted EBITDA of $340 million to $360 million, and adjusted EPS of $5.05 to $5.55.
- +7 more takeaways
Revvity Q1 2026 Earnings Call - Divests China Immunodiagnostics to Focus on AI-Driven Life Sciences Growth
Revvity kicked off 2026 with a strong quarter, reporting 3% organic growth, adjusted operating margins of 23.6%, and EPS of $1.06, beating expectations. The defining move of the call was the decision ...
- Revvity reported Q1 2026 revenue of $711 million, with 3% organic growth, adjusted operating margins of 23.6%, and adjusted EPS of $1.06, all beating guidance.
- The company announced a strategic divestiture of its China immunodiagnostics business, which represented ~6% of 2025 revenue, due to persistent policy headwinds and high capital requirements for local manufacturing.
- Pro forma Q1 organic growth excluding China immunodiagnostics would have been 6%, with pro forma adjusted operating margins of 24% and EPS of $1.04.
- +11 more takeaways
Texas Capital Bancshares Q1 2026 Earnings Call - Record Fee Income and Dividend Initiation Signal Platform Maturity
Texas Capital Bancshares delivered a quarter defined by structural momentum rather than cyclical luck. Fee income hit a record $58.8 million, driven by an 89% surge in investment banking and broad-bas...
- Fee income reached a record $58.8 million in Q1 2026, up 59% year-over-year, with all three focus areas—investment banking, treasury, and wealth management—delivering record quarterly contributions.
- Investment banking fees surged 89% year-over-year to $42.3 million, supported by $11 billion in debt arrangements and over $1 billion in equity raises, highlighting the firm's role as a top middle-market arranger.
- Texas Capital Bancshares initiated a quarterly common stock dividend of $0.20 per share, signaling confidence in sustainable earnings and a shift toward mature capital return policies.
- +7 more takeaways
James River Group Holdings Q1 2026 Earnings Call - Earnings Dented by Reinsurance Charge, But Core Underwriting Remains Disciplined
James River Group Holdings reported a net loss of $10.9 million for Q1 2026, a sharp reversal from the $7.6 million net income in the prior year period. The result was heavily distorted by a $6.7 mill...
- Net loss of $10.9 million reported for Q1 2026, compared to $7.6 million net income in Q1 2025.
- A $6.7 million reinsurance reinstatement charge on a legacy 2022 casualty treaty drove the loss, adding ~5 points to the combined ratio.
- Excluding the reinstatement charge, operating earnings would have been $0.22 per diluted share, with a consolidated combined ratio of 99.7%.
- +10 more takeaways
California Water Service Group Q1 2026 Earnings Call - Revised Rate Case Approval Drives Infrastructure Momentum
California Water Service Group delivered Q1 2026 results that were squarely in line with expectations, despite a delayed General Rate Case. The highlight of the quarter was a 17.6% jump in infrastruct...
- Q1 2026 revenue reached $214.6 million, up from $204.0 million in the prior year period.
- Net income for Q1 2026 was $4.0 million, or $0.07 per diluted share, down from $13.3 million, or $0.22 per diluted share, in Q1 2025.
- Infrastructure capital investments surged 17.6% to $129.5 million in Q1, with total planned 2026 capital expenditures set at $627 million.
- +12 more takeaways
Crocs Q1 2026 Earnings Call - New Product Momentum Offsets Tariff and Geopolitical Headwinds
Crocs delivered a better-than-expected first quarter, posting $921 million in revenue despite a 2% reported decline, driven by strong direct-to-consumer growth and international expansion. Both the Cr...
- Total revenue of $921 million came in ahead of expectations, despite a 2% reported decline and 4% constant-currency drop, fueled by strong direct-to-consumer performance.
- Crocs brand revenue fell 2% to $767 million, but DTC grew 11% in North America despite pulling back on promotions, signaling product-led demand.
- HEYDUDE brand revenue declined 13% to $154 million, yet DTC rose 8% on lower performance marketing spend, indicating improving brand health and efficiency.
- +9 more takeaways
UFP Industries Q1 2026 Earnings Call - Deckorators Momentum and Strategic M&A Offset Macro Headwinds
UFP Industries reported a challenging first quarter for fiscal 2026, with net sales falling 8% year-over-year to $1.46 billion and adjusted EBITDA margin contracting to 7.6%. The decline was driven by...
- Net sales of $1.46 billion declined 8% year-over-year, driven by a 7% drop in units and a 1% decrease in pricing.
- Adjusted EBITDA margin contracted to 7.6% from 8.9% in the prior year period, with profitability impacted by higher medical and transportation costs.
- The Retail segment saw a 12% sales decline, but Deckorators delivered 2% unit growth, with Surestone sales surging 27% and wood plastic composite decking up 4%.
- +7 more takeaways
Amneal Pharmaceuticals Q1 2026 Earnings Call - Acquisition of Kashiv BioSciences Creates Integrated Biosimilars Leader
Amneal Pharmaceuticals is making a definitive move into the biosimilars arena by agreeing to acquire Kashiv BioSciences for $750 million in upfront cash and equity, a strategic play that instantly est...
- Amneal agrees to acquire Kashiv BioSciences in a $750 million upfront transaction (50% cash, 50% equity), creating a fully integrated global biosimilars leader.
- The deal provides direct access to over $300 million in worldwide biologic loss of exclusivity over the next decade, targeting a combined portfolio of 20+ biosimilars programs.
- Q1 2026 revenue grew 4% to $723 million, with adjusted EBITDA up 19% to $202 million and EPS up 29% to $0.27, driven by strong performance in women’s health and specialty products.
- +7 more takeaways
HSBC Holdings Q1 2026 Earnings Call - Wealth Flows Surge Amid Strategic Simplification and Geopolitical Stress Testing
HSBC delivered a robust first quarter with annualized return on tangible equity of 18.7 percent, driven by broad-based revenue growth across all four business segments. The bank upgraded full year ban...
- Annualized return on tangible equity reached 18.7 percent, the highest level in nearly two decades, signaling strong capital generation and execution discipline.
- Full year banking net interest income guidance upgraded to around $46 billion, reflecting an improved interest rate outlook and structural hedge reinvestment tailwinds.
- Wealth fee income surged 15 percent year on year to $2.7 billion, with net new money of $39 billion, 87 percent sourced from Asia, highlighting deepening client engagement in Hong Kong.
- +7 more takeaways
Amerant Bancorp {Q1} {2026} Earnings Call - Aggressive Cost Cuts and Venezuelan Deposit Surge Drive Turnaround
Amerant Bancorp’s first quarter 2026 results mark a decisive shift from crisis management to disciplined execution. The bank slashed non-interest expenses by 37.3% quarter-over-quarter, unlocking a $3...
- Non-interest expenses plummeted 37.3% to $66.9 million, reflecting $30 million in annualized cost savings from contract renegotiations and operational efficiencies.
- Diluted EPS surged to $0.44, a stark improvement from $0.07 in Q4 2025, driven by expense management and a cleaner balance sheet.
- Venezuelan deposits contributed $95 million to the $188 million total international deposit growth, with new inflows costing sub-1%.
- +12 more takeaways